Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

× No keyword cloud information.

54 in total

1. Substituted 9-benzyladenines: inhibitors of inflammation associated with the delayed hypersensitivity skin reaction.

Authors: R J Wojnar; R J Brittain
Journal: Agents Actions Date: 1975-05

2. Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors: Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal: Pharm Res Date: 2004-01 Impact factor: 4.200

3. Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors: G B Elion
Journal: In Vitro Cell Dev Biol Date: 1989-04

4. Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).

Authors: Chunmei Wang; Wenwei Lin; Hilaire Playa; Shan Sun; Keyuna Cameron; John K Buolamwini
Journal: Biochem Pharmacol Date: 2013-09-07 Impact factor: 5.858

5. The effect of D-penicillamine of the skeletal development of rat foetuses.

Authors: H J Merker; L Franke; T Günther
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1975 Impact factor: 3.000

Review 6. Immunobiology and immunopharmacology of organ allograft rejection.

Authors: M Suthanthiran; T B Strom
Journal: J Clin Immunol Date: 1995-07 Impact factor: 8.317

Review 7. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

8. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.

Authors: L V Ramilo-Torno; V I Avramis
Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333

9. Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.

Authors: G Whelan; S Sherlock
Journal: Gut Date: 1972-11 Impact factor: 23.059

10. Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.

Authors: S A Al-Safi; J L Maddocks
Journal: Br J Clin Pharmacol Date: 1984-04 Impact factor: 4.335